The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Research Report 2025
Synopsis
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.
The global Peptide Receptor Radionuclide Therapy (PRRT) market was valued at US$ 1043 million in 2023 and is anticipated to reach US$ 4478.8 million by 2030, witnessing a CAGR of 17.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Peptide Receptor Radionuclide Therapy (PRRT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Receptor Radionuclide Therapy (PRRT).
Report Scope
The Peptide Receptor Radionuclide Therapy (PRRT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Receptor Radionuclide Therapy (PRRT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Receptor Radionuclide Therapy (PRRT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
Curium Pharmaceuticals
Segment by Type
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Receptor Radionuclide Therapy (PRRT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.
The global Peptide Receptor Radionuclide Therapy (PRRT) market was valued at US$ 1043 million in 2023 and is anticipated to reach US$ 4478.8 million by 2030, witnessing a CAGR of 17.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Peptide Receptor Radionuclide Therapy (PRRT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Receptor Radionuclide Therapy (PRRT).
Report Scope
The Peptide Receptor Radionuclide Therapy (PRRT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Receptor Radionuclide Therapy (PRRT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Receptor Radionuclide Therapy (PRRT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
Curium Pharmaceuticals
Segment by Type
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Receptor Radionuclide Therapy (PRRT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gastroenteropancreatic Neuroendocrine Tumor
1.2.3 Foregut Neuroendocrine Tumor
1.2.4 Midgut Neuroendocrine Tumor
1.2.5 Hindgut Neuroendocrine Tumor
1.3 Market by Application
1.3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Perspective (2019-2030)
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Region
2.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Region (2019-2024)
2.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Region (2025-2030)
2.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Dynamics
2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Industry Trends
2.3.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers
2.3.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges
2.3.4 Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue
3.1.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue (2019-2024)
3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue
3.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio
3.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2023
3.5 Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Area Served
3.6 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
3.7 Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Type
4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2019-2024)
4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2025-2030)
5 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Application
5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Application (2019-2024)
5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2019-2030)
6.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024)
6.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2019-2030)
7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024)
7.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2019-2030)
8.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2019-2030)
9.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024)
9.4 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2019-2030)
10.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.1.4 Bayer Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.2.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Lantheus
11.3.1 Lantheus Company Detail
11.3.2 Lantheus Business Overview
11.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.3.4 Lantheus Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2019-2024)
11.3.5 Lantheus Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Detail
11.4.2 Aurobindo Pharma Business Overview
11.4.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.4.4 Aurobindo Pharma Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2019-2024)
11.4.5 Aurobindo Pharma Recent Development
11.5 Mundipharma
11.5.1 Mundipharma Company Detail
11.5.2 Mundipharma Business Overview
11.5.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.5.4 Mundipharma Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2019-2024)
11.5.5 Mundipharma Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Detail
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.6.4 Curium Pharmaceuticals Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2019-2024)
11.6.5 Curium Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
